Skip to main content

Day: March 3, 2025

Turmalina Announces Closing of Share Financing

VANCOUVER, British Columbia, March 03, 2025 (GLOBE NEWSWIRE) — Turmalina Metals Corp. (“Turmalina”, or the “Company”; TBX-TSXV, TBXXF-OTCQX, 3RI-FSE) is pleased to announce that it has closed its previously announced non-brokered private placement offering (the “Offering”) for aggregate gross proceeds of $5,000,000, from the issuance of 100,000,000 common shares in the capital of the Company (the “Shares”) at a price of $0.05 per Share. The net proceeds of the Offering will be used to satisfy continuing costs associated with the Company’s properties and for general working capital purposes. In connection with closing of the Offering, the Company issued an aggregate of 1,746,500 Shares to certain eligible arm’s length finders. All securities issued in connection with closing of the Offering are subject to a statutory hold period...

Continue reading

DMG Blockchain Solutions Reports First Quarter 2025 Results and February Operations Update

VANCOUVER, British Columbia, March 03, 2025 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB: DMGGF) (FRANKFURT: 6AX) (“DMG” or the “Company”), a vertically integrated blockchain and data center technology company, today announces its fiscal first quarter 2025 financial results. All financial references are in Canadian Dollars unless specified otherwise. Readers are encouraged to review the Company’s December 31, 2024 quarterly unaudited financial statements and management’s discussion and analysis thereof for a fulsome assessment of the Company’s performance and applicable risk factors, available at www.sedarplus.ca. Q1 2025 Financial Results HighlightsRevenue: $11.6 million in Q1 2025, up 97% from $5.9 million in Q4 2024 and up 20% from $9.7 million in Q1 2024. Bitcoin Mined: 97...

Continue reading

Microchip Technology to Present at the Raymond James 46ᵗʰ Annual Investors Conference

CHANDLER, Ariz., March 03, 2025 (GLOBE NEWSWIRE) — (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Raymond James 46ᵗʰ Annual Investors Conference on Wednesday, March 5, 2025 at 9:50 a.m. (Eastern Time). Presenting for the Company will be Mr. Eric Bjornholt, Senior Vice President and Chief Financial Officer, and Mr. Sajid Daudi, Head of Investor Relations. A live webcast of the presentation will be made available by Raymond James, and can be accessed on the Microchip website at www.microchip.com. Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company’s Securities and Exchange Commission filings. Copies...

Continue reading

MariMed Completes Acquisition of First State Compassion, Strengthening Market Position in Delaware

NORWOOD, Mass., March 03, 2025 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed,” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, announced today it has completed its acquisition of First State Compassion Center (“FSCC”), the leading cannabis operator in Delaware, in accordance with the terms of the previously announced Omnibus Agreement entered into with FSCC in July 2023. The acquisition integrates FSCC’s cultivation and processing facilities, and two dispensaries into MariMed’s fully vertical operations, further enhancing the Company’s revenue and profitability. The approval of MariMed to become the owner of FSCC was facilitated by the state permitting FSCC to transition from a not-for-profit to a for-profit business. The timing is ideal for MariMed, as Delaware is expected to commence adult-use...

Continue reading

Plug Power Announces Continued Cash Flow Improvement and Progress on Path to Profitability

SLINGERLANDS, N.Y., March 03, 2025 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in the hydrogen economy, today provided an update on its strategic and operational progress and path to profitability. This past year of 2024 marked a pivotal commercial inflection point for Plug as the Company advanced its hydrogen generation platform and scaled new product offerings, such as its electrolyzer solutions. Commensurate with these strategic initiatives driving the commercial inflection point, and in response to evolving market conditions, Plug took decisive steps in 2024 to improve margins and cash flows by optimizing operations, streamlining its workforce, consolidating facilities, increasing pricing on certain offerings, reducing working capital, and reprioritizing certain hydrogen and new product investments. These...

Continue reading

Guggenheim Investments Announces March 2025 Closed-End Fund Distributions

NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) — Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the “Funds” and each, a “Fund”).The following dates apply to the distributions:Record Date March 14, 2025Ex-Dividend Date March 14, 2025Payable Date  March 31, 2025Distribution ScheduleNYSE Ticker Closed-End Fund Name Distribution Per Share Change from Previous Distribution FrequencyAVK Advent Convertible and Income Fund $0.1172†   MonthlyGBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust $0.12573†   MonthlyGOF Guggenheim Strategic Opportunities Fund $0.1821†   MonthlyGUG Guggenheim Active Allocation Fund $0.11875†   Monthly† A portion...

Continue reading

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

MELBOURNE, Australia and INDIANAPOLIS, March 04, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) invites investors to join a webinar showcasing the Company’s late-stage and next-generation radiotherapeutic candidates in urologic oncology. In this education session, Telix and global key opinion leaders will provide an overview on the development of its therapeutic candidates in prostate and kidney cancers:Neeraj Agarwal, MD, Professor of Medicine and Presidential Endowed Chair of Cancer Research at Huntsman Cancer Institute in Salt Lake City, UT, will discuss the ProstACT Global Phase 3 trial of TLX591 (177Lu rosopatamab tetraxetan), Telix’s lead radio antibody-drug conjugate (rADC) therapy candidate in prostate cancer. Eric Jonasch, MD, Professor of Medicine in the Department...

Continue reading

W&T Offshore Announces Fourth Quarter and Full Year 2024 Results Including Year-End 2024 Proved Reserves, Provides Guidance for 2025 and Declares Dividend for First Quarter of 2025

HOUSTON, March 03, 2025 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) (“W&T,” the “Company” or “us”) today reported operational and financial results for the fourth quarter and full year 2024, including the Company’s year-end 2024 reserve report. Detailed guidance for the first quarter of 2025 and full year 2025 was also provided, and W&T announced its dividend for the first quarter of 2025. This press release includes non-GAAP financial measures, including Adjusted Net Loss, Adjusted EBITDA, Free Cash Flow, Net Debt and PV-10 which are described and reconciled to the most comparable GAAP measures below in the accompanying tables under “Non-GAAP Information.” Key highlights for the fourth quarter of 2024, the full year 2024 and since year end 2024 include:Delivered production in full year 2024 of 33.3 thousand...

Continue reading

FG Communities Completes 42nd Manufactured Housing Acquisition with Community in Taylorsville

Acquisition adds fourth location in Taylorsville and further solidifies presence in region MOORESVILLE, N.C., March 03, 2025 (GLOBE NEWSWIRE) — FG Communities, whose mission is to preserve and improve affordable housing by acquiring and operating manufactured housing communities, is excited to announce its most recent acquisition in Taylorsville, North Carolina. This is FG Communities’s fourth acquisition in Taylorsville and is near other portfolio communities in Statesville, Morganton, Hickory, Conover, and Claremont. Residents of the park can reach Lake Norman, the largest lake in North Carolina, in just over 30 minutes. The lake has over 520 miles of shoreline and is known for outdoor recreation including boating, fishing, hiking, and biking. The Lake Norman area has experienced rapid expansion, with the population of some lake...

Continue reading

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Fourth Quarter 2024 Total Revenues of $194.7 million; Full Year 2024 Total Revenues of $1.04 billion Fourth Quarter 2024 Net Loss of $31.3 million, decrease in Net Loss of 37% versus prior year Fourth Quarter 2024 Adjusted EBITDA of $21.0 million, increase of 518% versus prior year Full Year 2024 Adjusted EBITDA of $183.1 million, compares favorably to a loss of $22.3 million in 2023 Guiding to 2025 Adjusted EBITDA of $150 – $200 million and improved gross marginsGAITHERSBURG, Md., March 03, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2024. “As we close out 2024, I’m proud to share we delivered favorable full-year financial results driven by our core products, all the while, completing a series of strategic stabilization...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.